Brand
All brands
Country
All countries
Language
All languages
Therapeutic Area
All areas
Indication
All indications
Type
All types
Competitor
All competitors
Overview
SEO Data - Novartis
Impressions
584,364
▲ 23.5%Share of Voice
100.00%
Average Position
13.00
Clicks
6,536
Share of Clicks
6.34%
CTR
1.12%
Visibility Index - Novartis vs. Competitors
5.25%
Novartis
0.62%
JnJ
0.55%
Abbvie
0.99%
Roche
0.42%
Biogen
0.86%
Sanofi
0.85%
Pfizer
0.74%
Astrazeneca
0.15%
BMS
0.09%
MSD / Merck
0.09%
Lilly
0.09%
UCB
OVERALL DOMINANCE - NOVARTIS VS. COMPETITORS
Visibility Index Over Time
Position Over Time
Visibility per Brand
| Brand | Brand Visibility | Top Competitor | Competitor Visibility |
|---|---|---|---|
| Cosentyx | 32.05% | Roche | 18.88% |
| Leqvio | 26.04% | Sanofi | 14.02% |
| Kisqali | 21.17% | Pfizer | 11.59% |
| Kesimpta | 20.74% | Sanofi | 10.87% |
Visibility - Brand, Language, Keywords
Share of Voice - Branded vs. Unbranded
Visibility Index - Therapeutic Area
Visibility Index - Indication
Keyword Dominance - Language
| Language | Average Position | Visibility Index | Share of Voice |
|---|---|---|---|
| en | 28.31 | 10.26% | 0.58% |
| de | 29.81 | 9.53% | 0.41% |
| pt | 32.33 | 2.54% | 0.27% |
| jp | 32.25 | 8.16% | 0.14% |
| fr | 33.30 | 4.51% | 0.10% |
TOP 10 - Evolution of Average Position
Visibility Index - Country
| # | Website country | Average Position | Visibility Index | Share of Voice |
|---|---|---|---|---|
| 1. | US | 25 | 0.47% | 18.88% |
| 2. | GB | 29 | 0.34% | 14.02% |
| 3. | CA | 29 | 0.35% | 13.16% |
| 4. | DE | 30 | 0.30% | 12.02% |
| 5. | IN | 31 | 0.29% | 11.59% |
| 6. | FR | 31 | 0.27% | 10.87% |
| 7. | BR | 32 | 0.25% | 9.87% |
| 8. | JP | 32 | 0.23% | 9.59% |
Top Keywords
020
03,000
0%100%
0%5%
| Keyword | Domain | Type | Focus Br... | Therapeutic Area | Indication | AIO | Search Volume | Rank | Visibility I... | Share of Voice |
|---|---|---|---|---|---|---|---|---|---|---|
| caps syndrom | anflammati.org | Disease | Cosentyx | Oncology | Lung Cancer | 325 | 1 | 91.9% | 0.07% | |
| pso | aen.it | Disease | Leqvio | Immunology | Rheumatoid Arthritis | 715 | 1 | 91.9% | 0.49% | |
| cosentyx and antibiotics | maynic.org | Branded | Cosentyx | Oncology | Breast Cancer | 11 | 1 | 91.9% | 0% | |
| einblutungen unter der haut | lebet-blutk.de | Treatment | Leqvio | Immunology | Rheumatoid Arthritis | 1,045 | 1 | 91.9% | 0.38% | |
| desmielinizacion | nnrehab.es | Disease | Kesimpta | Cardiology | COPD | 325 | 1 | 91.9% | 0.27% | |
| akne inversa achsel | abare.de | Treatment | Leqvio | Immunology | Rheumatoid Arthritis | 176 | 1 | 91.9% | 0.03% | |
| cosentix | cx.com | Branded | Kisqali | Oncology | Lung Cancer | 1,045 | 1 | 91.9% | 0.14% | |
| leicht schuppenflechte anfang | psis-bund.org | Generic | Kesimpta | Neurology | Melanoma | 550 | 1 | 91.9% | 0.09% | |
| colesterole hdl | ll.it | HCP | Kisqali | Respiratory | COPD | 264 | 1 | 91.9% | 0.02% | |
| auflamtorische erkra... | aammati.org | Generic | Cosentyx | Oncology | Breast Cancer | 28 | 1 | 91.9% | 0.01% |